Dr Daniel Lewis Barnett, MD | |
328 S Lubec Rd, Lubec, ME 04652-3636 | |
(207) 733-2311 | |
Not Available |
Full Name | Dr Daniel Lewis Barnett |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | 328 S Lubec Rd, Lubec, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326326919 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 8523 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Lewis Barnett, MD 328 S Lubec Rd, Lubec, ME 04652-3636 Ph: (207) 733-2311 | Dr Daniel Lewis Barnett, MD 328 S Lubec Rd, Lubec, ME 04652-3636 Ph: (207) 733-2311 |
News Archive
From 2001 to 2006, Canada's health care providers were less likely to move from one province or territory to another, with migration rates decreasing to their lowest levels in two decades for some occupational groups. According to a new study released today by the Canadian Institute for Health Information, this decline was particularly apparent for physicians.
YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today provided an update on the proposed transaction which would result in the merger of Cytopia Ltd. into YM, details of which were announced on October 5, 2009.
ARYx Therapeutics Inc., a biopharmaceutical company, today announced that it has retained Cowen and Company to explore strategic options for ARYx.
A new immunotherapy screening prototype developed by University of California, Irvine researchers can quickly create individualized cancer treatments that will allow physicians to effectively target tumors without the side effects of standard cancer drugs.
The mere mention of the word "herpes" usually conjures negative images and stereotypes, but most people have been infected with some form of the virus. For most, a sore appears, heals and is forgotten, although the virus remains latent just waiting for the right circumstances to come back. Now, the mystery behind what triggers the virus to become active again is closer to being solved thanks to new research published in the Journal of Leukocyte Biology's November 2012 issue.
› Verified 2 days ago